Vonoprazan (Takecab)
Jump to navigation
Jump to search
Acid pump antagonist
History of changes in PMDA indication
- 2014-12-26: Initial approval for the treatment of gastric ulcer, duodenal ulcer, reflux esophagitis, prevention of recurrence of gastric or duodenal ulcer in patients treated with low-dose aspirin, prevention of recurrence of gastric or duodenal ulcer in patients treated with non-steroidal anti-inflammatory drugs (NSAIDs), and aid to eradication of Helicobacter pylori in patients with gastric ulcer, duodenal ulcer, gastric MALT lymphoma, idiopathic thrombocytopenic purpura, Helicobacter pylori gastritis, and stomach after endoscopic treatment for early gastric cancer.
Also known as
- Generic name: vonoprazan fumarate
- Brand name: Takecab